639
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

Factors associated with injecting-related risk behaviors among people who inject drugs: a systematic review and meta-analysis study

, MD, , PhD, , PhD, , MD, , PhD, , MSc, , PhDORCID Icon & , MSc show all

References

  • Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, Stone J, Cunningham EB, Trickey A, Dumchev K, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–e1207. doi:10.1016/S2214-109X(17)30375-3.
  • Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385–98. doi:10.1016/S1473-3099(16)30325-5.
  • Noroozi A, Mirzazadeh A, Farhoudian A, Hajebi A, Khankeh HR, Higgs P, Sharifi H, Armoon B, Noroozi M. Impact of HIV status notification on risk behaviors among men who inject drugs in Kermanshah, West of Iran. J Res Health Sci. 2016;16(3):116–21.
  • Noroozi M, Ahmadi S, Armoon B, Jorjoran Shushtari Z, Sharhani A, Ahounbar E, Karimi S. e, Rahmani A, Mokhayeri Y, Qorbani M, et al. Social determinants associated with risky sexual behaviors among men who inject drugs in Kermanshah, Western Iran. J Subst Use. 2018;23(6):591–6. doi:10.1080/14659891.2018.1459905.
  • Rezaie F, Noroozi A, Armoon B, et al. Social determinants and hepatitis C among people who inject drugs in Kermanshah, Iran: socioeconomic status, homelessness, and sufficient syringe coverage. J Subst Use. 2017;22(5):474–478.
  • Palmateer NE, Hutchinson SJ, Innes H, Schnier C, Wu O, Goldberg DJ, Hickman M. Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. Int J Drug Policy. 2013;24(2):85–100. doi:10.1016/j.drugpo.2012.08.006.
  • Pilarinos A, Kennedy MC, McNeil R, Dong H, Kerr T, DeBeck K. The association between residential eviction and syringe sharing among a prospective cohort of street-involved youth. Harm Reduct J. 2017;14(1):24doi:10.1186/s12954-017-0150-5.
  • Cox J, Morissette C, De P, Tremblay C, Allard R, Graves L, Stephenson R, Roy E. Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users. Subst Use Misuse. 2009;44(4):548–68. doi:10.1080/10826080802544349.
  • Bowden S, McCaw R, White P, Crofts N, Aitken C. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat. 2005;12(3):322–4. doi:10.1111/j.1365-2893.2005.00592.x.
  • Herring BL, Page-Shafer K, Tobler LH, Delwart EL. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis. 2004;190(8):1396–403. doi:10.1086/424491.
  • Smith BD, Jewett A, Burt RD, Zibbell JE, Yartel AK, DiNenno E. “To share or not to share?” Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants?” J Infect Dis. 2013;208(12):1934–42. doi:10.1093/infdis/jit520.
  • Bryant J, Treloar C. Risk practices and other characteristics of injecting drug users who obtain injecting equipment from pharmacies and personal networks. Int J Drug Policy. 2006;17(5):418–24. doi:10.1016/j.drugpo.2006.07.004.
  • De P, Cox J, Boivin J-F, Platt RW, Jolly AM. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health. 2008;85(1):77–89. doi:10.1007/s11524-007-9225-z.
  • Noroozi M, Noroozi A, Sharifi H, Harouni GG, Marshall BDL, Ghisvand H, Qorbani M, Armoon B. Needle and syringe programs and HIV-related risk behaviors among men who inject drugs: a multilevel analysis of two cities in Iran. Intj Behav Med. 2019;26(1):50–8. doi:10.1007/s12529-018-9758-4.
  • Noroozi M, Rahimi E, Ghisvand H, Qorbani M, Sharifi H, Noroozi A, Farhoudian A, Marshall BDL, Jorjoran Shoshtari Z, Karimi SE, et al. Decomposition of Economic Inequality in Needle and Syringe Programs Utilization to its Determinants among Men Who Inject Drugs in Tehran using Blinder-Oaxaca Decomposition Method. Subst Use Misuse. 2018;53(7):1170–6. doi:10.1080/10826084.2017.1400567.
  • Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med. 2000;51(12):1771–82. doi:10.1016/s0277-9536(00)00109-x.
  • Cao W, Treloar C. Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales . Drug Alcohol Rev. 2006;25(5):439–44. doi:10.1080/09595230600891282.
  • Armoon B, Noroozi M, Jorjoran Shushtari Z, Sharhani A, Ahounbar E, Karimi S, Ahmadi S, Farhoudian A, Rahmani A, Abbasi M, et al. Factors associated with HIV risk perception among people who inject drugs: findings from a cross-sectional behavioral survey in Kermanshah, Iran. J Subst Use. 2018;23(1):63–6. doi:10.1080/14659891.2017.1348554.
  • Noroozi M, Ahounbar E, Karimi SE, Ahmadi S, Najafi M, Bazrafshan A, Shushtari ZJ, Farhadi MH, Higgs P, Rezaei F, et al. HIV Risk perception and risky behavior among people who inject drugs in Kermanshah, Western Iran. Int J Behav Med. 2017;24(4):613–8. doi:10.1007/s12529-017-9634-7.
  • Bazrafshan MR, Noroozi M, Ghisvand H, Noroozi A, Alibeigi N, Abbasi M, Higgs P, Armoon B. Comparing injecting risk behaviors of long-term injectors with new injectors in Tehran, Iran. Subst Use Misuse. 2019;54(2):185–90. doi:10.1080/10826084.2018.1491055.
  • Fernandes RM, Cary M, Duarte G, Jesus G, Alarcão J, Torre C, Costa S, Costa J, Carneiro AV. Effectiveness of needle and syringe Programmes in people who inject drugs – an overview of systematic reviews. BMC Public Health. 2017;17(1):309doi:10.1186/s12889-017-4210-2.
  • Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17(9):2878–92. doi:10.1007/s10461-013-0593-y.
  • Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–48. doi:10.1093/ije/dyt243.
  • Ksobiech K. A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Educ Prev. 2003;15(3):257–68. doi:10.1521/aeap.15.4.257.23828.
  • Moradi-Joo M, Ghiasvand H, Noroozi M, Armoon B, Noroozi A, Karimy M, Rostami A, Mirzaee MS, Hemmat M. Prevalence of skin and soft tissue infections and its related high-risk behaviors among people who inject drugs: a systematic review and meta-analysis. Journal of Substance Use. 2019;24(4):350–60. doi:10.1080/14659891.2019.1572805.
  • Cross JE, Saunders CM, Bartelli D. The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Quality and Quantity. 1998;32(2):165–80. [Mismatch] doi:10.1023/A:1004398707484.
  • Topp L, Iversen J, Baldry E, Maher L, CoA N, Collaboration of Australian NSPs. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health. 2013;90(4):699–716. doi:10.1007/s11524-012-9730-6.
  • Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, the PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj. 2015;349(jan02 1):g7647–g7647. doi:10.1136/bmj.g7647.
  • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) groupJama. 2000;283(15):2008–12. doi:10.1001/jama.283.15.2008.
  • Bayat A-H, Mohammadi R, Moradi-Joo M, Bayani A, Ahounbar E, Higgs P, Hemmat M, Haghgoo A, Armoon B. HIV and drug related stigma and risk-taking behaviors among people who inject drugs: a systematic review and meta-analysis. J Addict Dis. 2020;38(1):71–83. doi:10.1080/10550887.2020.1718264.
  • Ghiasvand H, Bayani A, Noroozi A, Marshall BD, Koohestani HR, Hemmat M, Mirzaee MS, Bayat AH, Noroozi M, Ahounbar E, et al. Comparing injecting and sexual risk behaviors of long-term injectors with new injectors: A meta-analysis. J Addict Dis. 2018;37(3-4):233–44. doi:10.1080/10550887.2019.1666622.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. biometrics. 1977;33(1):159–74. doi:10.2307/2529310.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:10.1007/s10654-010-9491-z.
  • Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Vol 4: John Wiley & Sons, Chichester, West Sussex, England,; 2011.
  • Hansen BT, Hukkelberg SS, Haldorsen T, Eriksen T, Skare GB, Nygård M. Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women. BMC Public Health. 2011;11(1):264doi:10.1186/1471-2458-11-264.
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101. doi:10.2307/2533446.
  • Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. doi:10.1136/bmj.315.7109.629.
  • Bozinoff N, Wood E, Dong HR, Richardson L, Kerr T, DeBeck K. Syringe sharing among a prospective cohort of street-involved youth: implications for needle distribution programs. AIDS Behav. 2017;21(9):2717–25. doi:10.1007/s10461-017-1762-1.
  • Hartgers C, Buning EC, Vansanten GW, Verster AD, Coutinho RA. The impact of the needle and syringe-exchange program in Amsterdam on injecting risk behavior. AIDS. 1989;3(9):571–6.
  • Fisher DG, Harbke CR, Canty JR, Reynolds GL. Needle and syringe cleaning practices among injection drug users. J Drug Educ. 2002;32(2):167–78. doi:10.2190/2HMC-W575-5M2E-G3LU.
  • Huo DZ, Ouellet LJ. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. J Acquir Immune Defic Syndr. 2007;45(1):108–14. doi:10.1097/QAI.0b013e318050d260.
  • Jenness SM, Hagan H, Liu K-L, Wendel T, Murrill CS. Continuing HIV risk in New York city injection drug users: the association of syringe source and syringe sharing. Subst Use Misuse. 2011;46(2-3):192–200. doi:10.3109/10826084.2011.521467.
  • Rachlis B, Lloyd-Smith E, Small W, Tobin D, Stone D, Li K, Wood E, Kerr T. Harmful microinjecting practices among a cohort of injection drug users in Vancouver Canada. Subst Use Misuse. 2010;45(9):1351–66. doi:10.3109/10826081003767643.
  • Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, Schechter MT, O'Shaughnessy MV. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction. 1997;92(10):1339–47.
  • Hartgers C, van Ameijden EJ, van den Hoek JA, Coutinho RA. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Public Health Reports (Washington, DC: 1974). 1992;107(6):675–81.
  • Belanger D, Godin G, Alary M, Noel L, Cote N, Claessens C. Prediction of needle sharing among injection drug users. J Appl Social Pyschol. 2002;32(7):1361–78. doi:10.1111/j.1559-1816.2002.tb01441.x.
  • Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. J Acquir Immune Defic Syndr (1999). 2004;37(2):1307–12.
  • Rezaie F, Farhadi MH, Farhoudian A, Najafi M, Bazrafshan A, Higgs P, Mohammadi Shahboulagh F, Ranjbar M, Vameghi M, Abbasi M, et al. Access to needle and syringe programs and the relationship to equipment sharing among people who inject drugs in Kermanshah, Iran. J Subst Use. 2017;22(4):397–402. doi:10.1080/14659891.2016.1227384.
  • Latkin CA, Forman VL. Patterns of needle acquisition and sociobehavioral correlates of needle exchange program attendance in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr (1999). 2001;27(4):398–404.
  • Kerr T, Small W, Buchner C, Zhang R, Li K, Montaner J, Wood E. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100(8):1449–53. doi:10.2105/AJPH.2009.178467.
  • Kerr T, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K, Zhang R, Wood E. Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok, Thailand. Drug Alcohol Rev. 2010;29(2):157–61. doi:10.1111/j.1465-3362.2009.00093.x.
  • Hartgers C, Van Ameijden E, Van Den Hoek J, Coutinho RA. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Public Health Rep. 1992;107(6):675–81.
  • Bealanger D, Godin G, Alary M, Bernard PM. Factors Explaining the Intention to Use Condoms Among Injecting Drug Users Participating in a Needle‐Exchange Program. J Appl Social Pyschol. 2002;32(5):1047–63. doi:10.1111/j.1559-1816.2002.tb00255.x.
  • Rafiey H, Narenjiha H, Shirinbayan P, Noori R, Javadipour M, Roshanpajouh M, Samiei M, Assari S. Needle and syringe sharing among Iranian drug injectors. Harm Reduct J. 2009;6(1):21doi:10.1186/1477-7517-6-21.
  • Horyniak D, Dietze P, Degenhardt L, Higgs P, McIlwraith F, Alati R, Bruno R, Lenton S, Burns L. The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs. Drug Alcohol Depend. 2013;132(3):541–6. doi:10.1016/j.drugalcdep.2013.03.021.
  • Smyth BP, Barry J, Keenan E. Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction. 2001;96(5):717–27. doi:10.1046/j.1360-0443.2001.9657177.x.
  • Strathdee SA, Patrick DM, Currie SL, Cornelisse PGA, Rekart ML, Montaner JSG, Schechter MT, Oʼshaughnessy MV. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–F65. doi:10.1097/00002030-199708000-00001.
  • Gossop M, Griffiths P, Powis B, Williamson S, Fountain J, Strang J. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors. AIDS Care Psychol Care. 1997;9(6):651–60. doi:10.1080/09540129750124687.
  • Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997;26(6):1359–66. doi:10.1093/ije/26.6.1359.
  • Neaigus A, Friedman SR, Jose B, et al. High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr. 1996;11(5):499–509.
  • Klee H, Morris J. The role of needle exchanges in modifying sharing behaviour: cross‐study comparisons 1989–1993. Addiction. 1995;90(12):1635–45. doi:10.1111/j.1360-0443.1995.tb02834.x.
  • Salmaso S, Conti S, Sasse H. Drug use and HIV-1 infection: report from the Second Italian Multicenter Study. J Acquir Immune Defic Syndr. 1991;4(6):607–13.
  • Carruthers S, Loxley W. Hepatitis C and young drug users: are they about to join the epidemic? Aust J Public Health. 1995;19(4):421–4. doi:10.1111/j.1753-6405.1995.tb00398.x.
  • Cassin S, Geoghegan T, Cox G. Young injectors: a comparative analysis of risk behaviour. Ir J Med Sci. 1998;167(4):234–7. doi:10.1007/BF02937420.
  • Fennema JS, Ameijden EJ, Hoek A, Coutinho RA. Young and recent‐onset injecting drug users are at higher risk for HIV. Addiction. 1997;92(11):1457–65. doi:10.1111/j.1360-0443.1997.tb02867.x.
  • Saxon AJ, Calsyn DA, Jackson TR. Longitudinal changes in injection behaviors in a cohort of injection drug users. Addiction. 1994;89(2):191–202. doi:10.1111/j.1360-0443.1994.tb00878.x.
  • Peters A, Davies T, Richardson A. Multi-site samples of injecting drug users in Edinburgh: prevalence and correlates of risky injecting practices . Addiction. 1998;93(2):253–67. doi:10.1046/j.1360-0443.1998.9322539.x.
  • Stark K, Muller R, Wirth D, Bienzle U, Pauli G, Guggenmoos‐Holzmann I. Determinants of HIV infection and recent risk behaviour among injecting drug users in Berlin by site of recruitment. Addiction. 1995;90(10):1367–75. doi:10.1111/j.1360-0443.1995.tb03554.x.
  • Baker A, Kochan N, Dixon J, Wodak A, Heather N. HIV risk‐taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction. 1995;90(4):545–54. doi:10.1111/j.1360-0443.1995.tb02189.x.
  • Kemp R, Miller J, Lungley S, Baker M. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. The NZ Med J. 1998;111(1060):50–3.
  • Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003;80(1):137–46. doi:10.1093/jurban/jtg137.
  • Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy. 2014;25(1):105–11. doi:10.1016/j.drugpo.2013.06.005.
  • Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94(5):675–83. doi:10.1046/j.1360-0443.1999.9456755.x.
  • Tassiopoulos K, Bernstein J, Bernstein E. Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study. Addict Sci Clin Pract. 2013;8(1):20. doi:10.1186/1940-0640-8-20.
  • Maher L, Jalaludin B, Chant K, Kaldor J. Hepatitis C among intravenous drug users. Epidemiology. 2005;16(3):423.
  • Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore)). 1995;74(4):212–20. doi:10.1097/00005792-199507000-00005.
  • Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, Monterroso ER, Garfein RS. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155(7):645–53. doi:10.1093/aje/155.7.645.
  • Miller CL, Kerr T, Frankish JC, Spittal PM, Li K, Schechter MT, Wood E. Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst Use Misuse. 2006;41(2):199–210. doi:10.1080/10826080500391795.
  • Noroozi M, Marshall BDL, Noroozi A, Armoon B, Sharifi H, Farhoudian A, Ghiasvand H, Vameghi M, Rezaei O, Sayadnasiri M, et al. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach. Drug Alcohol Rev. 2018;37:S303–S308. doi:10.1111/dar.12646.
  • Hayashi K, Wood E, Suwannawong P, Kaplan K, Qi J, Kerr T. Methamphetamine injection and syringe sharing among a community-recruited sample of injection drug users in Bangkok, Thailand. Drug Alcohol Depend. 2011;115(1-2):145–9. doi:10.1016/j.drugalcdep.2010.10.018.
  • Wood E, Tyndall MW, Spittal PM, Li K, Anis AH, Hogg RS, Montaner JSG, O'Shaughnessy MV, Schechter MT. Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ. 2003;168(2):165–9.
  • Stoneberg DM, Shukla RK, Magness MB. Global methamphetamine trends: an evolving problem. Int Crim Just Rev. 2018;28(2):136–61. doi:10.1177/1057567717730104.
  • Cunningham JK, Liu LM. Impacts of federal precursor chemical regulations on methamphetamine arrests. Addiction. 2005;100(4):479–88. doi:10.1111/j.1360-0443.2005.01032.x.
  • Kerr T, Wood E, Grafstein E, Ishida T, Shannon K, Lai C, Montaner J, Tyndall MW. High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf)). 2005;27(1):62–6. doi:10.1093/pubmed/fdh189.
  • El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. People who inject drugs in intimate relationships: it takes two to combat HIV. Curr HIV/AIDS Rep. 2014;11(1):45–51. doi:10.1007/s11904-013-0192-6.
  • Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JSG, O'Shaughnessy MV, Schechter MT. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002;16(6):941–3. doi:10.1097/00002030-200204120-00021.
  • Frischer M, Haw S, Bloor M, Goldberg D, Green S, McKeganey N, Covell R. Modeling the behavior and attributes of injecting drug users: a new approach to identifying HIV risk practices. Int J Addict. 1993;28(2):129–52. doi:10.3109/10826089309039619.
  • Colledge S, Leung J, Larney S, Peacock A, Grebely J, Hickman M, Cunningham E, Trickey A, Stone J, Vickerman P, et al. Frequency of injecting among people who inject drugs: a systematic review and meta-analysis. Int J Drug Policy. 2020;76:102619doi:10.1016/j.drugpo.2019.102619.
  • Ballester J, Valentine G, Sofuoglu M. Pharmacological treatments for methamphetamine addiction: current status and future directions. Expert Rev Clin Pharmacol. 2017;10(3):305–14. doi:10.1080/17512433.2017.1268916.
  • Harris M, Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct J. 2013;10(1):7doi:10.1186/1477-7517-10-7.
  • Krawczyk C, Molitor F, Ruiz J, et al. Methamphetamine use and HIV risk behaviors among heterosexual men—preliminary results from five northern California counties, December 2001–November 2003. MMWR. 2006;55(10):273–7.
  • Rawson RA, Gonzales R, Pearce V, Ang A, Marinelli-Casey P, Brummer J, Methamphetamine Treatment Project Corporate Authors Methamphetamine dependence and human immunodeficiency virus risk behavior. J Subst Abuse Treat. 2008;35(3):279–84. doi:10.1016/j.jsat.2007.11.003.
  • Perngmark P, Vanichseni S, Celentano DD. The Thai HIV/AIDS epidemic at 15 years: sustained needle sharing among southern Thai drug injectors. Drug Alcohol Depend. 2008;92(1-3):183–90. doi:10.1016/j.drugalcdep.2007.07.014.
  • Zule WA, Desmond DP. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am J Drug Alcohol Abuse. 1999;25(1):1–23. doi:10.1081/ada-100101843.
  • Walsh C, Hubley AM, To MJ, Norena M, Gadermann A, Farrell S, Hwang SW, Palepu A. The effect of forensic events on health status and housing stability among homeless and vulnerably housed individuals: A cohort study. PloS One. 2019;14(2):e0211704doi:10.1371/journal.pone.0211704.
  • Corneil TA, Kuyper LM, Shoveller J, Hogg RS, Li K, Spittal PM, Schechter MT, Wood E. Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place. 2006;12(1):79–85. doi:10.1016/j.healthplace.2004.10.004.
  • Wagner KD, Simon-Freeman R, Bluthenthal RN. The association between law enforcement encounters and syringe sharing among IDUs on skid row: a mixed methods analysis. AIDS Behav. 2013;17(8):2637–43. doi:10.1007/s10461-013-0488-y.
  • Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav. 2005;9(3):251–65. doi:10.1007/s10461-005-9000-7.
  • Briggs D, Rhodes T, Marks D, Kimber J, Holloway G, Jones S. Injecting drug use and unstable housing: scope for structural interventions in harm reduction. Drugs: education, Prevention and Policy. 2009;16(5):436–50. doi:10.1080/09687630802697685.
  • Hunt N, Lloyd C, Kimber J, Tompkins C. Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. Int J Drug Policy. 2007;18(1):62–5. doi:10.1016/j.drugpo.2006.11.018.
  • Neaigus A, Friedman SR, Curtis R, Des Jarlais DC, Furst RT, Jose B, Mota P, Stepherson B, Sufian M, Ward T, et al. The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med. 1994;38(1):67–78. doi:10.1016/0277-9536(94)90301-8.
  • Sharifi H, Mirzazadeh A, Noroozi A, Marshall BDL, Farhoudian A, Higgs P, Vameghi M, Mohhamadi Shahboulaghi F, Qorbani M, Massah O, et al. Patterns of HIV risks and related factors among people who inject drugs in Kermanshah, Iran: a latent class analysis. J Psychoactive Drugs. 2017;49(1):69–73. doi:10.1080/02791072.2016.1262568.
  • Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Subst Use Misuse. 1998;33(11):2323–51. doi:10.3109/10826089809056260.
  • Rachlis BS, Wood E, Zhang R, Montaner JS, Kerr T. High rates of homelessness among a cohort of street-involved youth. Health Place. 2009;15(1):10–7. doi:10.1016/j.healthplace.2008.01.008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.